Cambridge Heart inks development, distribution deal

Justine Varieur Cadet | | Cardiovascular Business | Heart Rhythm
Cambridge Heart has signed a non-exclusive development and distribution agreement with an undisclosed U.S. stress test manufacturer to develop a microvolt T-Wave alternans (MTWA) module.

The original equipment manufacturer MTWA module will be integrated into cardiac stress testing equipment to address sudden cardiac arrest prevention, according to the Bedford, Mass.-based Cambridge Heart.

The companies said that development of the module is anticipated to take nine to 15 months, based on production and regulatory approval timelines.

Justine Varieur Cadet

Related Content

Predicting sudden cardiac death after a heart attack may be impossible—for now
Concomitant ablation surgery during heart operations boosts long-term survival
Johnson & Johnson MedTech gains FDA approval for Varipulse PFA system
Boston Scientific agrees to acquire AFib ablation company
Heart Rhythm Society launches new group focused on EP advocacy
FDA approves Medtronic’s new all-in-one mapping and ablation system for AFib

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Design by Adaptive Theme
Trimed Popup
Trimed Popup